Seer, Inc. Logo

Seer, Inc.

SEER

(1.2)
Stock Price

1,81 USD

-19.05% ROA

-20.03% ROE

-1.39x PER

Market Cap.

117.757.518,00 USD

7.1% DER

0% Yield

-545.32% NPM

Seer, Inc. Stock Analysis

Seer, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Seer, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.23x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (7%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The company's Graham number suggests that its stock price is underestimated, implying that it may present a compelling investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-19.72%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-18.77%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (-1), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Seer, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Seer, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Sell
4 Stoch RSI Sell

Seer, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Seer, Inc. Revenue
Year Revenue Growth
2018 0
2019 58.000 100%
2020 656.000 91.16%
2021 6.394.000 89.74%
2022 14.685.000 56.46%
2023 15.256.000 3.74%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Seer, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2018 3.776.000
2019 12.393.000 69.53%
2020 18.942.000 34.57%
2021 29.121.000 34.95%
2022 45.797.000 36.41%
2023 52.928.000 13.47%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Seer, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 2.982.000
2019 4.606.000 35.26%
2020 15.363.000 70.02%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Seer, Inc. EBITDA
Year EBITDA Growth
2018 -6.276.000
2019 -15.332.000 59.07%
2020 -32.766.000 53.21%
2021 -71.147.000 53.95%
2022 -92.966.000 23.47%
2023 -97.600.000 4.75%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Seer, Inc. Gross Profit
Year Gross Profit Growth
2018 0
2019 58.000 100%
2020 656.000 91.16%
2021 3.189.000 79.43%
2022 6.742.000 52.7%
2023 7.232.000 6.78%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Seer, Inc. Net Profit
Year Net Profit Growth
2018 -6.307.000
2019 -16.043.000 60.69%
2020 -31.169.000 48.53%
2021 -68.633.000 54.59%
2022 -88.697.000 22.62%
2023 -84.352.000 -5.15%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Seer, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 0 0%
2020 -2 100%
2021 -1 -100%
2022 -1 0%
2023 -1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Seer, Inc. Free Cashflow
Year Free Cashflow Growth
2018 -4.819.000
2019 -17.204.000 71.99%
2020 -25.362.000 32.17%
2021 -53.269.000 52.39%
2022 -71.045.000 25.02%
2023 -18.612.000 -281.72%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Seer, Inc. Operating Cashflow
Year Operating Cashflow Growth
2018 -4.651.000
2019 -13.073.000 64.42%
2020 -20.828.000 37.23%
2021 -46.347.000 55.06%
2022 -60.780.000 23.75%
2023 -14.411.000 -321.76%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Seer, Inc. Capital Expenditure
Year Capital Expenditure Growth
2018 168.000
2019 4.131.000 95.93%
2020 4.534.000 8.89%
2021 6.922.000 34.5%
2022 10.265.000 32.57%
2023 4.201.000 -144.35%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Seer, Inc. Equity
Year Equity Growth
2018 29.975.000
2019 87.679.000 65.81%
2020 431.609.000 79.69%
2021 502.916.000 14.18%
2022 446.993.000 -12.51%
2023 405.679.000 -10.18%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Seer, Inc. Assets
Year Assets Growth
2018 33.696.000
2019 93.236.000 63.86%
2020 442.319.000 78.92%
2021 539.139.000 17.96%
2022 487.929.000 -10.5%
2023 444.853.000 -9.68%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Seer, Inc. Liabilities
Year Liabilities Growth
2018 3.721.000
2019 5.557.000 33.04%
2020 10.710.000 48.11%
2021 36.223.000 70.43%
2022 40.936.000 11.51%
2023 39.174.000 -4.5%

Seer, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.23
Net Income per Share
-1.33
Price to Earning Ratio
-1.39x
Price To Sales Ratio
7.92x
POCF Ratio
-1.87
PFCF Ratio
-1.6
Price to Book Ratio
0.29
EV to Sales
7.41
EV Over EBITDA
-1.09
EV to Operating CashFlow
-1.75
EV to FreeCashFlow
-1.5
Earnings Yield
-0.72
FreeCashFlow Yield
-0.62
Market Cap
0,12 Bil.
Enterprise Value
0,11 Bil.
Graham Number
13.76
Graham NetNet
4.69

Income Statement Metrics

Net Income per Share
-1.33
Income Quality
0.69
ROE
-0.2
Return On Assets
-0.19
Return On Capital Employed
-0.25
Net Income per EBT
0.96
EBT Per Ebit
0.83
Ebit per Revenue
-6.83
Effective Tax Rate
0.15

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
3.67
Stock Based Compensation to Revenue
2.35
Gross Profit Margin
0.36
Operating Profit Margin
-6.83
Pretax Profit Margin
-5.68
Net Profit Margin
-5.45

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.99
Free CashFlow per Share
-1.15
Capex to Operating CashFlow
0.17
Capex to Revenue
-0.7
Capex to Depreciation
-2.05
Return on Invested Capital
-0.19
Return on Tangible Assets
-0.19
Days Sales Outstanding
190.25
Days Payables Outstanding
36.29
Days of Inventory on Hand
203.63
Receivables Turnover
1.92
Payables Turnover
10.06
Inventory Turnover
1.79
Capex per Share
-0.16

Balance Sheet

Cash per Share
5,18
Book Value per Share
6,35
Tangible Book Value per Share
6.35
Shareholders Equity per Share
6.35
Interest Debt per Share
0.4
Debt to Equity
0.07
Debt to Assets
0.06
Net Debt to EBITDA
0.08
Current Ratio
27.65
Tangible Asset Value
0,41 Bil.
Net Current Asset Value
0,31 Bil.
Invested Capital
0.07
Working Capital
0,33 Bil.
Intangibles to Total Assets
0
Average Receivables
0,01 Bil.
Average Payables
0,00 Bil.
Average Inventory
4744000
Debt to Market Cap
0.24

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Seer, Inc. Dividends
Year Dividends Growth

Seer, Inc. Profile

About Seer, Inc.

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

CEO
Dr. Omid C. Farokhzad M.D., Ph
Employee
147
Address
3800 Bridge Parkway
Redwood City, 94065

Seer, Inc. Executives & BODs

Seer, Inc. Executives & BODs
# Name Age
1 Mr. Joe Laws
Chief Technology Officer and Co-Founder
70
2 Ms. Elona Kogan Esq., J.D.
Chief Legal Officer,General Counsel & Secretary
70
3 Dr. Omid C. Farokhzad M.D., Ph.D.
Founder, Chief Executive Officer, & Chair of the Board of Directors
70
4 Mr. David R. Horn
President,Treasurer & Chief Financial Officer
70
5 Kenny Ross
Chief Operations & Product Officer
70
6 Ms. Marissa Dixon
Chief People Officer
70
7 Dr. Serafim Batzoglou Ph.D.
Chief Data Officer
70
8 Mr. Martin Goldberg Ph.D.
Senior Vice President of Development
70
9 Dr. Asim Siddiqui Ph.D.
Senior Vice President of Research & Tech Development
70
10 Dr. Christopher E. Mason Ph.D.
Member of Scientific Advisory Board
70

Seer, Inc. Competitors